The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Anzalone Christopher Richard since year 2005.
The trader's CIK number is 1423029.
At the time of this reporting, Anzalone Christopher Richard is the Chief Executive Officer of Arrowhead Pharmaceuticals, Inc. .
(stock ticker symbol ARWR).
See this page for all insider trading activities at Arrowhead Pharmaceuticals, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2018-03-16||ARWR||Arrowhead Pharmaceuticals, Inc.||Sale||26,000||7.40||192,400|
|2018-03-15||ARWR||Arrowhead Pharmaceuticals, Inc.||Sale||100,000||7.41||741,000|
|2018-03-14||ARWR||Arrowhead Pharmaceuticals, Inc.||Sale||100,000||7.44||744,000|
|2018-03-13||ARWR||Arrowhead Pharmaceuticals, Inc.||Sale||100,000||7.43||743,000|
|2016-06-30||ARWR||Arrowhead Pharmaceuticals, Inc.||Option Ex||15,772||5.09||80,279|
|2014-10-15||ARWR||Arrowhead Pharmaceuticals, Inc.||Buy||16,000||6.32||101,120|
|2010-08-31||ARWR||Arrowhead Pharmaceuticals, Inc.||Buy||10,000||.89||8,900|
|2010-08-27||ARWR||Arrowhead Pharmaceuticals, Inc.||Buy||10,000||.89||8,900|
|2008-08-22||ARWR||Arrowhead Pharmaceuticals, Inc.||Buy||164,000||.00||0|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Anzalone Christopher Richard (Chief Executive Officer of Arrowhead Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.